vs
Apellis Pharmaceuticals, Inc.（APLS）与Metallus Inc.（MTUS）财务数据对比。点击上方公司名可切换其他公司
Metallus Inc.的季度营收约是Apellis Pharmaceuticals, Inc.的1.3倍（$267.3M vs $199.9M），Metallus Inc.净利率更高（-5.3% vs -29.5%，领先24.1%），Metallus Inc.同比增速更快（11.1% vs -5.9%），Apellis Pharmaceuticals, Inc.自由现金流更多（$-14.3M vs $-37.2M），过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高（7.7% vs -8.8%）
Apellis Pharmaceuticals是一家临床阶段生物制药企业，专注于开发调节补体系统的靶向疗法，适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病，核心市场为美国及欧盟地区。
APLS vs MTUS — 直观对比
营收规模更大
MTUS
是对方的1.3倍
$199.9M
营收增速更快
MTUS
高出17.1%
-5.9%
净利率更高
MTUS
高出24.1%
-29.5%
自由现金流更多
APLS
多$22.9M
$-37.2M
两年增速更快
APLS
近两年复合增速
-8.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $199.9M | $267.3M |
| 净利润 | $-59.0M | $-14.3M |
| 毛利率 | — | 2.2% |
| 营业利润率 | -25.6% | -7.7% |
| 净利率 | -29.5% | -5.3% |
| 营收同比 | -5.9% | 11.1% |
| 净利润同比 | -62.2% | 33.2% |
| 每股收益（稀释后） | $-0.40 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APLSMTUS
| Q4 25 | $199.9M | $267.3M | ||
| Q3 25 | $458.6M | $305.9M | ||
| Q2 25 | $178.5M | $304.6M | ||
| Q1 25 | $166.8M | $280.5M | ||
| Q4 24 | $212.5M | $240.5M | ||
| Q3 24 | $196.8M | $227.2M | ||
| Q2 24 | $199.7M | $294.7M | ||
| Q1 24 | $172.3M | $321.6M |
净利润APLSMTUS
| Q4 25 | $-59.0M | $-14.3M | ||
| Q3 25 | $215.7M | $8.1M | ||
| Q2 25 | $-42.2M | $3.7M | ||
| Q1 25 | $-92.2M | $1.3M | ||
| Q4 24 | $-36.4M | $-21.4M | ||
| Q3 24 | $-57.4M | $-5.9M | ||
| Q2 24 | $-37.7M | $4.6M | ||
| Q1 24 | $-66.4M | $24.0M |
毛利率APLSMTUS
| Q4 25 | — | 2.2% | ||
| Q3 25 | — | 11.4% | ||
| Q2 25 | — | 10.6% | ||
| Q1 25 | — | 7.8% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 15.7% |
营业利润率APLSMTUS
| Q4 25 | -25.6% | -7.7% | ||
| Q3 25 | 48.7% | 3.6% | ||
| Q2 25 | -18.6% | 2.8% | ||
| Q1 25 | -50.0% | 1.0% | ||
| Q4 24 | -12.3% | -10.1% | ||
| Q3 24 | -24.0% | -3.1% | ||
| Q2 24 | -14.7% | 2.1% | ||
| Q1 24 | -36.0% | 9.3% |
净利率APLSMTUS
| Q4 25 | -29.5% | -5.3% | ||
| Q3 25 | 47.0% | 2.6% | ||
| Q2 25 | -23.6% | 1.2% | ||
| Q1 25 | -55.3% | 0.5% | ||
| Q4 24 | -17.1% | -8.9% | ||
| Q3 24 | -29.2% | -2.6% | ||
| Q2 24 | -18.9% | 1.6% | ||
| Q1 24 | -38.5% | 7.5% |
每股收益（稀释后）APLSMTUS
| Q4 25 | $-0.40 | $-0.34 | ||
| Q3 25 | $1.67 | $0.19 | ||
| Q2 25 | $-0.33 | $0.09 | ||
| Q1 25 | $-0.74 | $0.03 | ||
| Q4 24 | $-0.30 | $-0.46 | ||
| Q3 24 | $-0.46 | $-0.13 | ||
| Q2 24 | $-0.30 | $0.10 | ||
| Q1 24 | $-0.54 | $0.52 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $466.2M | $156.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $370.1M | $686.0M |
| 总资产 | $1.1B | $1.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资APLSMTUS
| Q4 25 | $466.2M | $156.7M | ||
| Q3 25 | $479.2M | $191.5M | ||
| Q2 25 | $370.0M | $190.8M | ||
| Q1 25 | $358.4M | $180.3M | ||
| Q4 24 | $411.3M | $240.7M | ||
| Q3 24 | $396.9M | $254.6M | ||
| Q2 24 | $360.1M | $272.8M | ||
| Q1 24 | $325.9M | $278.1M |
总债务APLSMTUS
| Q4 25 | — | — | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $5.4M | ||
| Q4 24 | — | $5.4M | ||
| Q3 24 | — | $13.2M | ||
| Q2 24 | — | $13.2M | ||
| Q1 24 | $93.1M | $13.2M |
股东权益APLSMTUS
| Q4 25 | $370.1M | $686.0M | ||
| Q3 25 | $401.2M | $697.7M | ||
| Q2 25 | $156.3M | $690.0M | ||
| Q1 25 | $164.2M | $686.1M | ||
| Q4 24 | $228.5M | $690.5M | ||
| Q3 24 | $237.1M | $712.7M | ||
| Q2 24 | $264.3M | $736.3M | ||
| Q1 24 | $266.7M | $739.3M |
总资产APLSMTUS
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | $1.2B | ||
| Q2 25 | $821.4M | $1.1B | ||
| Q1 25 | $807.3M | $1.1B | ||
| Q4 24 | $885.1M | $1.1B | ||
| Q3 24 | $901.9M | $1.1B | ||
| Q2 24 | $904.5M | $1.1B | ||
| Q1 24 | $831.9M | $1.2B |
负债/权益比APLSMTUS
| Q4 25 | — | — | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | — | 0.01× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | 0.35× | 0.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.2M | $-1.9M |
| 自由现金流经营现金流 - 资本支出 | $-14.3M | $-37.2M |
| 自由现金流率自由现金流/营收 | -7.1% | -13.9% |
| 资本支出强度资本支出/营收 | 0.1% | 13.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $45.0M | $-93.0M |
8季度趋势，按日历期对齐
经营现金流APLSMTUS
| Q4 25 | $-14.2M | $-1.9M | ||
| Q3 25 | $108.5M | $22.0M | ||
| Q2 25 | $4.4M | $34.8M | ||
| Q1 25 | $-53.4M | $-38.9M | ||
| Q4 24 | $19.4M | $13.9M | ||
| Q3 24 | $34.1M | $-15.3M | ||
| Q2 24 | $-8.3M | $8.3M | ||
| Q1 24 | $-133.0M | $33.4M |
自由现金流APLSMTUS
| Q4 25 | $-14.3M | $-37.2M | ||
| Q3 25 | $108.3M | $-6.4M | ||
| Q2 25 | $4.4M | $17.0M | ||
| Q1 25 | $-53.4M | $-66.4M | ||
| Q4 24 | $19.3M | $-1.3M | ||
| Q3 24 | — | $-32.9M | ||
| Q2 24 | $-8.4M | $-5.8M | ||
| Q1 24 | $-133.3M | $16.0M |
自由现金流率APLSMTUS
| Q4 25 | -7.1% | -13.9% | ||
| Q3 25 | 23.6% | -2.1% | ||
| Q2 25 | 2.5% | 5.6% | ||
| Q1 25 | -32.0% | -23.7% | ||
| Q4 24 | 9.1% | -0.5% | ||
| Q3 24 | — | -14.5% | ||
| Q2 24 | -4.2% | -2.0% | ||
| Q1 24 | -77.3% | 5.0% |
资本支出强度APLSMTUS
| Q4 25 | 0.1% | 13.2% | ||
| Q3 25 | 0.0% | 9.3% | ||
| Q2 25 | 0.0% | 5.8% | ||
| Q1 25 | 0.0% | 9.8% | ||
| Q4 24 | 0.0% | 6.3% | ||
| Q3 24 | 0.0% | 7.7% | ||
| Q2 24 | 0.0% | 4.8% | ||
| Q1 24 | 0.2% | 5.4% |
现金转化率APLSMTUS
| Q4 25 | — | — | ||
| Q3 25 | 0.50× | 2.72× | ||
| Q2 25 | — | 9.41× | ||
| Q1 25 | — | -29.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 1.80× | ||
| Q1 24 | — | 1.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |
MTUS
| Industrial Market Sector | $95.3M | 36% |
| Manufactured Components | $67.8M | 25% |
| Aerospace And Defense | $39.6M | 15% |
| Seamless Mechanical Tubing | $31.3M | 12% |
| Energy Market Sector | $18.3M | 7% |
| Other | $11.3M | 4% |
| Other Market Sector | $3.7M | 1% |
